Patent Assignment
Reel/Frame 056707/0184
Confirmatory License
Recorded: 2021-06-29
Pages: 2
USPTO hasn’t posted the scanned image for this recording yet. Order a certified copy below.
Order Certified Copy
Assignor
UNIVERSITY OF CHICAGO
Executed: 2021-06-25
Assignee
NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Chelerythrine-Based Therapies for Cancer
Patent:
6,426,351 →
Application:
09/637,816 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 24, 2001
From: KUFE, DONALD W.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 011746/0496 →
Assignment of Assignor's Interest
Apr 24, 2001
From: WEICHSELBAUM, RALPH R.; CHMURA, STEVEN J.; DOLAN, MARY E.
To: ARCH DEVELOPMENT CORPORATION
Reel/Frame 011746/0499 →
Confirmatory License
Jun 25, 2018
From: UNIVERSITY OF CHICAGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046419/0454 →
Confirmatory License
Nov 1, 2018
From: UNIVERSITY OF CHICAGO
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047400/0191 →